EPPIC researchers present in first MOHCCN Seminar Series

Researchers from TFRI's Enhanced Pancreatic Cancer Profiling for Individualized Care presented during the first event of the Marathon of Hope Cancer Centres Network Seminar Series.
The event included a keynote address by Dr. Daniel Renouf, and presentations from Dr. Yifan Wang, and Drs. James Topham and Erica Tsang. Dr. George Zogopoulos moderated the event.
Below you can see a video of the entire presentation.
The event included a keynote address by Dr. Daniel Renouf, and presentations from Dr. Yifan Wang, and Drs. James Topham and Erica Tsang. Dr. George Zogopoulos moderated the event.
Related Team Member
-
Daniel
MOHCCN Steering CommitteeConsortium LeaderWorking Group Member
Renouf
-
Regional Consortia
BC Cancer Consortium
- British Columbia
The overall vision of the BC Cancer Consortium is to further strengthen our province-wide research capabilities and partnerships, to improve our ability to support innovation in clinical care, and fir...Read more -
Regional Consortia
BC Cancer Consortium
- British Columbia
The overall vision of the BC Cancer Consortium is to further strengthen our province-wide research capabilities and partnerships, to improve our ability to support innovation in clinical care, and fir...Read more -
Regional Consortia
BC Cancer Consortium
- British Columbia
The overall vision of the BC Cancer Consortium is to further strengthen our province-wide research capabilities and partnerships, to improve our ability to support innovation in clinical care, and fir...Read more -
Regional Consortia
BC Cancer Consortium
- British Columbia
The overall vision of the BC Cancer Consortium is to further strengthen our province-wide research capabilities and partnerships, to improve our ability to support innovation in clinical care, and fir...Read more -
Regional Consortia
BC Cancer Consortium
- British Columbia
The overall vision of the BC Cancer Consortium is to further strengthen our province-wide research capabilities and partnerships, to improve our ability to support innovation in clinical care, and fir...Read more
Related News
-
New study shows how comprehensive sequencing and molecular tumour boards can help put precision oncology into practice
Precision oncology is a promising approach for personalized cancer treatments. A new study from a Network-funded team demonstrates how it can be put into practice, and the challenges that remain to ma... -
Princess Margaret Cancer Consortium leadership and members share updates with the Network
The presentation was part of MOHCCN Seminar Series, which features virtual talks from MOHCCN research partner investigators and trainees, providing a platform for MOHCCN members to share their ongoing... -
New computational tool provides clues on how to target cancers with KMT2D mutations
A new study led by Dr. Marco Marra describes a strategy for identifying potential novel treatment targets in cancers driven by the loss of genes that are classified as tumour suppressors. -
Atlantic Cancer Consortium leadership and members share updates with the Network
The presentation was part of MOHCCN Seminar Series, which features virtual talks from MOHCCN research partner investigators and trainees, providing a platform for MOHCCN members to share their ongoing...